Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208071 · ClinicalTrials.gov registry record · NA
Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access
A NA study of Vascular Access, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07208071 is a NA study of Vascular Access that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07208071, a NA study of Vascular Access, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access for peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters.
Conditions Studied
Interventions
- OTHER Augmented reality headset use
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01-30 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07208071
The ClinicalTrials.gov registry entry for NCT07208071 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vascular Access appearing as the primary indexed condition, and to 1 intervention - of which Augmented reality headset use is the first listed.
NCT07208071 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT07208071 about?
NCT07208071 is a clinical study titled "Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access". This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access fo...
What is the current status of trial NCT07208071?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-30. Estimated completion is 2026-07.
What conditions does trial NCT07208071 study?
This clinical trial studies the following conditions: Vascular Access.
What interventions are being tested in trial NCT07208071?
The interventions under investigation include: Augmented reality headset use (OTHER).
Who is sponsoring clinical trial NCT07208071?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208071 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.